Pharmaron Beijing Co., Ltd. (SHE:300759)
China flag China · Delayed Price · Currency is CNY
29.90
-0.83 (-2.70%)
Feb 13, 2026, 3:04 PM CST

Pharmaron Beijing Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
50,63641,84647,37176,952106,39594,292
Market Cap Growth
24.50%-11.66%-38.44%-27.67%12.84%140.25%
Enterprise Value
55,31445,72651,40180,058105,73490,909
Last Close Price
29.9025.4928.4544.1660.9451.86
PE Ratio
34.9323.3329.5955.9864.0580.43
Forward PE
27.4326.2225.7235.7559.2381.97
PS Ratio
3.743.414.117.5014.2918.37
PB Ratio
3.342.943.587.1010.3310.56
P/TBV Ratio
4.704.165.2710.9014.5013.21
P/FCF Ratio
63.2878.07---283.35
P/OCF Ratio
15.6216.2417.2035.9151.7057.20
PEG Ratio
1.862.991.121.161.871.95
EV/Sales Ratio
4.083.734.467.8014.2017.71
EV/EBITDA Ratio
18.0417.7121.1535.9457.0968.62
EV/EBIT Ratio
28.5026.6030.4248.0473.0489.13
EV/FCF Ratio
69.1385.31---273.19
Debt / Equity Ratio
0.420.420.730.560.510.12
Debt / EBITDA Ratio
2.082.173.712.592.720.75
Debt / FCF Ratio
7.9811.15---3.16
Net Debt / Equity Ratio
0.270.200.230.30-0.09-0.31
Net Debt / EBITDA Ratio
1.421.131.231.46-0.48-2.11
Net Debt / FCF Ratio
5.145.43-26.63-4.0425.68-8.42
Asset Turnover
0.550.490.490.530.490.47
Inventory Turnover
6.867.607.237.559.9214.65
Quick Ratio
1.031.442.581.312.582.57
Current Ratio
1.501.802.981.672.902.80
Return on Equity (ROE)
9.66%12.48%13.14%12.80%16.85%13.68%
Return on Assets (ROA)
4.91%4.26%4.50%5.36%5.97%5.84%
Return on Invested Capital (ROIC)
8.14%8.45%9.59%11.51%15.80%17.11%
Return on Capital Employed (ROCE)
9.40%8.70%7.40%10.10%9.40%10.30%
Earnings Yield
2.99%4.29%3.38%1.79%1.56%1.24%
FCF Yield
1.58%1.28%-0.24%-1.05%-0.03%0.35%
Dividend Yield
0.67%0.78%0.70%0.45%0.33%0.26%
Payout Ratio
34.92%30.24%27.78%29.45%17.14%11.55%
Buyback Yield / Dilution
0.45%0.11%0.05%2.40%-1.97%-20.06%
Total Shareholder Return
1.11%0.89%0.76%2.85%-1.64%-19.80%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.